{"retracted":false,"update":{"timestamp":1470009600000,"doi":"10.1016/j.phrs.2016.04.017","type":"erratum"},"doi":"10.1016/j.phrs.2015.10.002","journal":"Pharmacological Research","publisher":"Elsevier BV","title":"Corrigendum to “Identification of cromolyn sodium as an anti-fibrotic agent targeting both hepatocytes and hepatic stellate cells” [Pharmacol. Res. 102 (2015) 176–183]"}
